Verition Fund Management LLC Nuvasive Inc Transaction History

Verition Fund Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$36.71 - $44.15 $3.38 Million - $4.07 Million	92,104 Added 859.98%	102,814 $4.28 Million
Q1 2023 May 15, 2023	BUY	$36.81 - $48.12 $394,235 - $515,365	10,710 New	10,710 $442,000
Q3 2022 Nov 14, 2022	BUY	$42.51 - $54.02 $598,710 - $760,817	14,084 Added 136.64%	24,391 $1.07 Million
Q2 2022 Aug 15, 2022	BUY	$46.84 - $59.75 $482,779 - $615,843	10,307 New	10,307 $507,000
Q1 2022 May 13, 2022	SELL	$48.09 - $57.79 $1.92 Million - $2.31 Million	-39,932 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$47.19 - $62.68 $1.88 Million - $2.5 Million	39,932 New	39,932 $2.1 Million
Q3 2021 Nov 15, 2021	SELL	$56.91 - $67.81 $173,290 - $206,481	-3,045 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$64.02 - $71.72 $194,940 - $218,387	3,045 New	3,045 $206,000
Q1 2019 May 15, 2019	SELL	$44.53 - $58.9 $224,921 - $297,503	-5,051 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$47.64 - $71.26 $240,629 - $359,934	5,051 New	5,051 $250,000
Q2 2018 Aug 15, 2018	SELL	$48.15 - $56.68 $1.17 Million - $1.38 Million	-24,302 Closed	0 $0
Q1 2018 May 16, 2018	BUY	$46.03 - $61.28 $1.12 Million - $1.49 Million	24,302 New	24,302 $1.27 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.